Antifungal Drugs Market, By Drug Class (Azoles, Echinocandins, Polyenes and Allylamines), By Indication, By Route of Administration, By Infection Type, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Antifungal Drugs Market size was valued at USD 15,678.23 Million in 2023, expanding at a CAGR of 3.79% from 2024 to 2032.
Antifungal medications are utilized to address fungal infections. Fungi present in the soil, air, and on the skin can result in conditions such as yeast infections, ringworm, and infections affecting the nails and skin. Inhalation of fungal spores may result in respiratory ailments. Individuals with compromised immune systems are at a higher risk for fungal infections that necessitate antifungal treatment. A range of antifungal drugs is available to combat these infections, with some being accessible over the counter while others require a prescription, contingent upon the specific medication.
Antifungal Drugs Market- Market Dynamics
The growing prevalence of fungal infections is anticipated to drive the growth of the market
Fungal infections, including candidiasis, aspergillosis, and cryptococcosis, are increasingly prevalent, especially among individuals with compromised immune systems, such as those suffering from HIV/AIDS, cancer, or those who have undergone organ transplants. The rising frequency of these infections, along with enhanced awareness and the availability of diagnostic tools, is driving the demand for effective antifungal therapies. According to the Centers for Disease Control and Prevention, over 75,000 hospitalizations and nearly 9 million outpatient visits for fungal diseases occur annually. Additionally, ongoing research and development in antifungal treatments, which includes the identification of new drug classes and innovative formulations, present substantial market opportunities. Nevertheless, the high cost of treatment may pose a challenge to market expansion.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ANTIFUNGAL DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Novartis AG
Pfizer, Inc.
Bayer AG
Sanofi
Merck & Co., Inc.
GlaxoSmithKline plc
Abbott
Glenmark
Enzon Pharmaceuticals, Inc.
Astellas Pharma, Inc.
Others
GLOBAL ANTIFUNGAL DRUGS MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019 - 2032
Azoles
Echinocandins
Polyenes
Allylamines
Others
GLOBAL ANTIFUNGAL DRUGS MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032
Dermatophytosis
Aspergillosis
Candidiasis
Others
GLOBAL ANTIFUNGAL DRUGS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032
Oral
Topical
Injectable
GLOBAL ANTIFUNGAL DRUGS MARKET, BY INFECTION TYPE- MARKET ANALYSIS, 2019 - 2032
Systemic antifungal infections
Superficial antifungal infections
GLOBAL ANTIFUNGAL DRUGS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
Hospital pharmacies
Retail pharmacies
Others
GLOBAL ANTIFUNGAL DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Antifungal Drugs Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Antifungal Drugs Market Snippet by Drug Class
2.1.2. Antifungal Drugs Market Snippet by Indication
2.1.3. Antifungal Drugs Market Snippet by Route of Administration
2.1.4. Antifungal Drugs Market Snippet by Infection Type
2.1.5. Antifungal Drugs Market Snippet by Distribution Channel
2.1.6. Antifungal Drugs Market Snippet by Country
2.1.7. Antifungal Drugs Market Snippet by Region
2.2. Competitive Insights
3. Antifungal Drugs Key Market Trends
3.1. Antifungal Drugs Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Antifungal Drugs Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Antifungal Drugs Market Opportunities
3.4. Antifungal Drugs Market Future Trends
4. Antifungal Drugs Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Antifungal Drugs Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Antifungal Drugs Market Landscape
6.1. Antifungal Drugs Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Antifungal Drugs Market – By Drug Class
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Class, 2023 & 2032 (%)
7.1.2. Azoles
7.1.3. Echinocandins
7.1.4. Polyenes
7.1.5. Allylamines
7.1.6. Others
8. Antifungal Drugs Market – By Indication
8.1. Overview
8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
8.1.2. Dermatophytosis
8.1.3. Aspergillosis
8.1.4. Candidiasis
8.1.5. Others
9. Antifungal Drugs Market – By Route of Administration
9.1. Overview
9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
9.1.2. Oral
9.1.3. Topical
9.1.4. Injectable
10. Antifungal Drugs Market – By Infection Type
10.1. Overview
10.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
10.1.2. Systemic antifungal infections
10.1.3. Superficial antifungal infections
11. Antifungal Drugs Market – By Distribution Channel
11.1. Overview
11.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
11.1.2. Hospital pharmacies
11.1.3. Retail pharmacies
11.1.4. Others
12. Antifungal Drugs Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Antifungal Drugs Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Antifungal Drugs Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.10. Italy
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.3.10.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.3.10.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.10.6. Italy Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.3.10.7. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.11. United Kingdom
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. United Kingdom Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.3.11.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.3.11.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.11.6. United Kingdom Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.3.11.7. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.12. France
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.3.12.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.3.12.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.12.6. France Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.3.12.7. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.13. Russia
12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.2. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.3.13.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.3.13.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.13.5. Russia Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.3.13.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.14. Netherlands
12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.2. Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.3.14.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.3.14.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.14.5. Netherlands Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.3.14.6. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.2. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.16. Poland
12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.2. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.3.16.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.16.5. Poland Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.3.17. Rest of Europe
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.3.17.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.3.17.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.3.17.6. Rest of the Europe Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.3.17.7. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Antifungal Drugs Key Manufacturers in Asia Pacific
12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.7. Asia Pacific Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.4.8. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.9. India
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.4.9.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.4.9.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.9.6. India Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.4.9.7. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.10. China
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.4.10.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.4.10.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.10.6. China Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.4.10.7. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.14. Thailand
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.4.14.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.4.14.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.14.6. Thailand Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.4.14.7. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.15. Indonesia
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.4.15.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.4.15.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.15.6. Indonesia Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.4.15.7. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5. Latin America
12.5.1. Overview
12.5.2. Antifungal Drugs Key Manufacturers in Latin America
12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. Latin America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.7. Latin America Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.5.8. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Antifungal Drugs Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Infection Type, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Antifungal Drugs Industry
13.1. Competitive Dashboard
13.2. Company Profiles
13.2.1. Novartis AG
13.2.2. Pfizer, Inc.
13.2.3. Bayer AG
13.2.4. Sanofi
13.2.5. Merck & Co., Inc.
13.2.6. GlaxoSmithKline plc
13.2.7. Abbott
13.2.8. Glenmark
13.2.9. Enzon Pharmaceuticals, Inc.
13.2.10. Astellas Pharma, Inc.
13.2.11. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
